
GSK claims first approval for Nucala in COPD
GSK gets FDA approval for Nucala in COPD, setting up a marketing tussle with Sanofi/Regeneron's Dupixent.
Newsletters and Deep Dive digital magazine
GSK gets FDA approval for Nucala in COPD, setting up a marketing tussle with Sanofi/Regeneron's Dupixent.
In a signal of a return to investor appetite for digital health stocks, Hinge Health has raised an impressive $437 million in an IPO.
The biopharma industry – long a powerhouse of scientific innovation – now stands at a critical inflection point.
There was good news for Johnson & Johnson at this week's ODAC meetings, but not for Roche, UroGen, and Pfizer.
Donald Trump's plan to introduce a most favoured nation (MFN) system of drug pricing controls is not quite what he first said it would be.
Editor's Picks
Newsletters and Deep Dive
digital magazine
Editor's Picks